Join our Whatsapp Community for Daily Price Sheets and News

Veeda Clinical Research Limited Shares

Financial Year: 2022

Financial Year: 2022

Financial Report Summary

VEEDA CLINICAL RESEARCH LIMITED Consolidated Financial Statements for period 01/04/2021 to 31/03/2022

Unless otherwise specified, all monetary values are in Millions of INR

Disclosure of General Information about the Company: Veeda Clinical Research Limited is domiciled in India. Previously known as Veeda Clinical Research Private Limited, it carries on the business of clinical research for pharmaceuticals. The consolidated financial statements comprise the Company, its subsidiaries (Bioneeds India Private Limited and its step-down subsidiaries Amthera Life Sciences Private Limited and Activin Chemicals & Pharmaceuticals Private Limited), and its joint venture, Ingenuity Biosciences Private Limited.

Auditors Report: SRBC&CO LLP is the name of the audit firm. Mehta Shardul Sukrut signed the report. The firm's registration number is 324982E/E300003, and the membership number of the auditor is 101974. The auditors' address is 21st Floor, B Wing, Privilon, Ambli BRT Road, Behind Iskon Temple, Off S G Highway, Ahmedabad-380059. The order of the companies auditor report is not applicable on the company. The auditor's report contains a qualification, reservation, or adverse remark.

Financial Performance (Statement of Profit and Loss):

  • Total Income: ₹2,931.09 (FY21-22) vs ₹2,343.83 (FY20-21).
  • Total Expenses: ₹2,616.35 (FY21-22) vs ₹1,488.49 (FY20-21).
  • Total profit (loss) for period: ₹504.58 (FY21-22) vs ₹629.67 (FY20-21).
  • Basic earnings per share: 10.26 INR/share (FY21-22) vs 15.39 INR/share (FY20-21)
  • Total comprehensive income: ₹505.23 (FY21-22) vs ₹628.5 (FY20-21). The company has presented comprehensive income OCI components net of tax.
  • Share of profit/loss of associates and joint ventures: ₹3.44 (FY21-22) vs -₹3.22 (FY20-21)
  • Income tax: Income tax expense is ₹154.77 (FY21-22) vs ₹222.45 (FY20-21).
  • Attributable to Other Comprehensive income, attributable to owners of parent is ₹0.23 (FY21-22) vs -₹1.17 (FY20-21)

Financial Position (Balance Sheet):

  • Total Assets: ₹6,775.41 (FY21-22) vs ₹2,851.76 (FY20-21).
  • Total Equity: ₹4,372.82 (FY21-22) vs ₹1,694.35976 (FY20-21).
  • Total Liabilities: ₹2,402.59 (FY21-22) vs ₹1,157.40024 (FY20-21).
  • Non-current assets: ₹3,577.94 (FY21-22) vs ₹1,646.56 (FY20-21).
  • Current assets: ₹3,197.47 (FY21-22) vs ₹1,205.2 (FY20-21).
  • Equity share capital: ₹105.787972 (FY21-22) vs ₹358.30976 (FY20-21).
  • Non-current liabilities: ₹889.09 (FY21-22) vs ₹409.89 (FY20-21).
  • Current liabilities: ₹1,513.5 (FY21-22) vs ₹747.51024 (FY20-21).

Cash Flow Statement:

  • Net cash flows from operating activities: ₹359.13 (FY21-22) vs ₹766.28 (FY20-21).
  • Net cash flows from investing activities: ₹-1,536.66 (FY21-22) vs ₹-925.81 (FY20-21).
  • Net cash flows from financing activities: ₹1,626.3 (FY21-22) vs ₹170.67 (FY20-21).
  • Cash and cash equivalents at end of period: ₹595.89 (FY21-22) vs ₹149.61 (FY20-21).

Equity Changes:

  • Increase in equity through other contributions by owners: ₹3,017.24 (FY21-22) vs ₹179.79 (FY20-21)
  • Total Equity at the end of period: ₹4,267.03 (FY21-22) vs ₹1,336.05 (FY20-21)

Subsidiaries, Associates and Joint Ventures:

  • Bioneeds India Private Limited became a subsidiary of Veeda Clinical Research Limited w.e.f. July 15, 2021. As of March 31, 2022, the Veeda holds 75.10% control.
  • Activin Chemicals & Pharmaceuticals Private Limited and Amthera Life Sciences Private Limited are subsidiaries of Bioneeds.
  • Veeda has a 50% stake in Joint venture - Ingenuity Biosciences Private Limited.

Accounting Policies:

  • Financial statements are prepared in accordance with Indian Accounting Standards (Ind AS).
  • The consolidated financial statements have been prepared on a historical cost basis, except for certain financial assets and liabilities measured at fair value/amortized cost.
  • The accrual basis of accounting has been followed.
  • Foreign currency transactions are recorded at functional currency spot rates.
  • Fair value is measured at each balance sheet date.
  • Intragroup balances and transactions are eliminated in consolidation.
  • Equity method is used for investments in associates and joint ventures.
  • Property, plant and equipment are stated at cost net of accumulated depreciation.
  • Intangible assets are amortized over their useful economic life.
  • Revenue from contract with customers is recognized when control of the services is transferred to the customer.
  • Government grants are recognized when reasonable assurance is received that conditions will be complied with.
  • Inventories are valued at the lower of cost and net realizable value.
  • There are no new standards that are notified, but not yet effective, up to the date of issuance of the Group's financial statements.

Additional Points:

  • The company had outstanding share options that affected earnings per share calculations.
  • The report includes a reconciliation of equity, profit, and comprehensive income.
  • There are certain income tax and service tax related contingent liabilies.
  • The company uses derivatives like forward contracts to hedge its foreign currency risks.

This summary encapsulates the financial standing and operations of Veeda Clinical Research Limited as of March 31, 2022, highlighting key aspects of its financial performance, position, and accounting practices.

Our Blogs

Our blog provides insightful information about unlisted shares, offering a deeper understanding of how these assets work, their potential benefits, and the risks involved. Whether you're new to unlisted shares or looking to expand your knowledge, we cover topics such as investment strategies, valuation methods, market trends, and regulatory aspects. Stay updated with expert tips and guides to navigate the unlisted share market effectively.

FAQ's

What are unlisted shares?

+

Unlisted shares are stocks of companies that are not listed on any stock exchange, meaning they are not publicly traded. These shares are typically available for trade in the private market through brokers, and can offer unique investment opportunities.

How can I buy unlisted shares?

+

You can buy unlisted shares through a broker or platform that specializes in unlisted share transactions. We provide a secure and easy way to purchase unlisted shares from top companies, ensuring a smooth transaction process.

What is the share price of unlisted companies?

+

The share prices of unlisted companies can fluctuate based on various factors like market demand, company performance, and private transactions. You can check the latest share prices for unlisted companies on our website for real-time updates.

Are unlisted shares a good investment?

+

Unlisted shares can offer higher growth potential, as they are typically not subject to the same market volatility as listed shares. However, they come with higher risk due to limited liquidity and availability of information. It's important to research thoroughly and consult experts before investing.

How can I sell unlisted shares?

+

To sell unlisted shares, you can connect with a broker or platform that facilitates the sale of private stocks. We help investors buy and sell unlisted shares with ease, ensuring that your transaction is handled professionally and securely.

What are the risks of investing in unlisted shares?

+

Yes, unlisted shares can eventually be listed on a stock exchange through an Initial Public Offering (IPO). This process allows the company to offer its shares publicly and be traded on major exchanges, potentially increasing liquidity and visibility.

What is the share price of unlisted companies?

+

Gains from unlisted shares are subject to capital gains tax in India. Short-term capital gains (if held for less than 24 months) are taxed at your applicable income tax rate, while long-term capital gains (if held for more than 24 months) are taxed at 20% with indexation benefits. Always consult a tax advisor for precise tax implications.

How do I know the current value of unlisted shares?

+

The value of unlisted shares is typically determined by private transactions, financial reports, and market demand. We provide the latest updates on share prices of unlisted companies, giving you the most accurate valuation available.

Is there a minimum investment amount for unlisted shares?

+

The minimum investment for unlisted shares can vary depending on the company and broker. Generally, the minimum investment is higher than for listed stocks, but we provide detailed information to help you make the best investment decisions.

Can I get a dividend from unlisted shares?

+

Yes, unlisted shares may pay dividends if the company has declared them. However, since these companies may be in their growth stage, dividend payments are not always guaranteed. It's important to check the company's financial health before investing.

How do I know which unlisted shares are worth investing in?

+

It's important to conduct thorough research on the company's financials, management, market potential, and overall business model. You can also seek professional advice from experts to help you choose unlisted shares with strong growth prospects.

Are unlisted shares taxed?

+

Gains from unlisted shares are subject to capital gains tax in India. Short-term capital gains (if held for less than 24 months) are taxed at your applicable income tax rate, while long-term capital gains (if held for more than 24 months) are taxed at 20% with indexation benefits. Always consult a tax advisor for precise tax implications.

WhatsAppContact Us